Sharma Vivek R, Thomas Shelia D, Miller Donald M, Rezzoug Francine
a Division of Medical Oncology/Hematology, Department of Medicine, James Graham Brown Cancer Center , University of Louisville , Louisville , KY , USA.
Cancer Invest. 2018;36(9-10):475-491. doi: 10.1080/07357907.2018.1527930. Epub 2018 Nov 5.
AS1411 is an antiproliferative DNA aptamer, which binds the ubiquitous protein, nucleolin. In this study, we show that constitutive overexpression of nucleolin confers increased sensitivity to the growth inhibitory effects of AS1411. HeLa cells overexpressing nucleolin have an increased growth rate and invasiveness relative to control cells. Nucleolin overexpressing cells demonstrate increased growth inhibition in response to the AS1411 treatment, which correlates with increased apoptosis and cell cycle arrest, when compared to non-transfected cells. AS1411 induces nucleolin expression at the RNA and protein level in HeLa cells, suggesting a feedback loop with important implications for the clinical use of AS1411.
AS1411是一种抗增殖DNA适配体,它能与普遍存在的蛋白质核仁素结合。在本研究中,我们发现核仁素的组成型过表达会增加细胞对AS1411生长抑制作用的敏感性。与对照细胞相比,过表达核仁素的HeLa细胞具有更高的生长速率和侵袭性。与未转染细胞相比,过表达核仁素的细胞在接受AS1411处理后表现出更强的生长抑制,这与细胞凋亡增加和细胞周期停滞相关。AS1411在HeLa细胞中诱导核仁素在RNA和蛋白质水平上的表达,这表明存在一个反馈回路,对AS1411的临床应用具有重要意义。